{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:53:12Z","timestamp":1790625192823,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic and Interventional Imaging"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.diii.2019.08.006","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T17:28:31Z","timestamp":1568136511000},"page":"59-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Differentiation between Fabry disease and hypertrophic cardiomyopathy with cardiac T1 mapping"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4528-9253","authenticated-orcid":false,"given":"E.","family":"Deborde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Dubourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bejar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-C.","family":"Brehin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Normant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Michelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7681-5252","authenticated-orcid":false,"given":"J.-N.","family":"Dacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diii.2019.08.006_bib0210","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/hrt.2005.063818","article-title":"The heart in Anderson-Fabry disease and other lysosomal storage disorders","volume":"93","author":"Linhart","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.diii.2019.08.006_bib0215","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-146-6-200703200-00007","article-title":"Narrative review: Fabry disease","volume":"146","author":"Clarke","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diii.2019.08.006_bib0220","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","article-title":"Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy","volume":"105","author":"Sachdev","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.diii.2019.08.006_bib0225","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.jacc.2007.06.062","article-title":"Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy","volume":"50","author":"Monserrat","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diii.2019.08.006_bib0230","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/STROKEAHA.112.663708","article-title":"Acute cerebrovascular disease in the young: the stroke in young Fabry patients study","volume":"44","author":"Rolfs","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.diii.2019.08.006_bib0235","doi-asserted-by":"crossref","first-page":"506","DOI":"10.5414\/CNP75506","article-title":"Fabry disease: results of the first UK hemodialysis screening study","volume":"75","author":"Wallin","year":"2011","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.diii.2019.08.006_bib0240","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.diii.2019.08.006_bib0245","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.CIR.0000091253.71282.04","article-title":"Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study","volume":"108","author":"Weidemann","year":"2003","journal-title":"Circulation."},{"key":"10.1016\/j.diii.2019.08.006_bib0250","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","article-title":"Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy: evidence for a better outcome with early treatment","volume":"119","author":"Weidemann","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.diii.2019.08.006_bib0255","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jacc.2009.04.094","article-title":"The role of cardiovascular magnetic resonance imaging in heart failure","volume":"54","author":"Karamitsos","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diii.2019.08.006_bib0260","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/CIRCULATIONAHA.111.089409","article-title":"Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality","volume":"126","author":"Wong","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.diii.2019.08.006_bib0265","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1161\/CIRCIMAGING.111.964965","article-title":"Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international, multicenter study","volume":"4","author":"Klem","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.diii.2019.08.006_bib0270","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/hrt.2006.104026","article-title":"Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa","volume":"94","author":"Hughes","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.diii.2019.08.006_bib0275","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","article-title":"Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping","volume":"6","author":"Sado","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.diii.2019.08.006_bib0280","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","volume":"42","author":"Maron","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diii.2019.08.006_bib0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2011.10.825","volume":"58","author":"Gersh","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diii.2019.08.006_bib0290","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.diii.2018.08.014","article-title":"Distribution of left ventricular trabeculation across age and gender in 140 healthy Caucasian subjects on MR imaging","volume":"99","author":"Bentatou","year":"2018","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2019.08.006_bib0295","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mrm.20110","article-title":"Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart","volume":"52","author":"Messroghli","year":"2004","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.diii.2019.08.006_bib0300","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1532-429X-15-56","article-title":"T1- and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision","volume":"15","author":"Kellman","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.diii.2019.08.006_bib0305","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12968-015-0111-7","article-title":"Normal values for cardiovascular magnetic resonance in adults and children","volume":"17","author":"Kawel-Boehm","year":"2015","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.diii.2019.08.006_bib0310","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1532-429X-15-13","article-title":"Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5T using ShMOLLI","volume":"15","author":"Piechnik","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.diii.2019.08.006_bib0315","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1532-429X-14-13","article-title":"Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"14","author":"Maron","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.diii.2019.08.006_bib0320","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.diii.2019.08.006_bib0325","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCIMAGING.113.000482","article-title":"T1 mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex","volume":"6","author":"Thompson","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.diii.2019.08.006_bib0330","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1148\/radiol.14140296","article-title":"Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE","volume":"272","author":"Roujol","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2019.08.006_bib0335","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/jmri.22753","article-title":"Myocardial T1 mapping with MRI: comparison of look-locker and MOLLI sequences","volume":"34","author":"Nacif","year":"2011","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.diii.2019.08.006_bib0340","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12968-017-0386-y","article-title":"Measurement of myocardial native T1 in cardiovascular diseases and norm in 1291 subjects","volume":"19","author":"Liu","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.diii.2019.08.006_bib0345","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1148\/radiol.2018172613","article-title":"Use of myocardial T1 mapping at 3.0T to differentiate Anderson-Fabry disease from hypertrophic cardiomyopathy","volume":"288","author":"Karur","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2019.08.006_bib0350","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12968-016-0302-x","article-title":"Myocardial T1-mapping at 3T using saturation-recovery: reference values, precision and comparison with MOLLI","volume":"18","author":"Weing\u00e4rtner","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.diii.2019.08.006_bib0355","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12968-014-0069-x","article-title":"Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study","volume":"16","author":"Dabir","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.diii.2019.08.006_bib0360","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jcmg.2011.01.020","article-title":"Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment","volume":"4","author":"Niemann","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.diii.2019.08.006_bib0365","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase a replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diii.2019.08.006_bib0370","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.carpath.2009.05.003","article-title":"A detailed pathologic examination of heart tissue from three older patients with Anderson-Fabry disease on enzyme replacement therapy","volume":"19","author":"Sheppard","year":"2010","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.diii.2019.08.006_bib0375","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12968-016-0233-6","article-title":"Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease","volume":"18","author":"Deva","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.diii.2019.08.006_bib0380","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.amjcard.2018.06.007","article-title":"Comparison of native T1, strain, and traditional measures of cardiovascular structure and function by cardiac magnetic resonance imaging in patients with Anderson-Fabry disease","volume":"122","author":"Wilson","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.diii.2019.08.006_bib0385","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jacc.2016.07.741","article-title":"Cardiac Fabry disease with late gadolinium enhancement is a chronic inflammatory cardiomyopathy","volume":"68","author":"Nordin","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diii.2019.08.006_bib0390","doi-asserted-by":"crossref","first-page":"P2","DOI":"10.1186\/1532-429X-18-S1-P2","article-title":"Reproducibility of native T1 mapping using ShMOLLI and MOLLI - implications for sample size calculation","volume":"18","author":"Bhuva","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.diii.2019.08.006_bib0395","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1532-429X-15-53","article-title":"Myocardial T1 and T2 mapping at 3T: reference values, influencing factors and implications","volume":"15","author":"Von Knobelsdorff-Brenkenhoff","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.diii.2019.08.006_bib0400","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1532-429X-14-88","article-title":"Comparison of T1 mapping techniques for ECV quantification: histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification","volume":"14","author":"Fontana","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.diii.2019.08.006_bib0405","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/CIRCIMAGING.112.979815","article-title":"Role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease","volume":"6","author":"Coelho-Filho","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.diii.2019.08.006_bib0410","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.diii.2017.12.003","article-title":"Variability induced by the MR imager in dynamic contrast-enhanced imaging of the prostate","volume":"99","author":"Brunelle","year":"2018","journal-title":"Diagn Interv Imaging"}],"container-title":["Diagnostic and Interventional Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211568419302013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211568419302013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:34:13Z","timestamp":1761932053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211568419302013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S2211568419302013"],"URL":"https:\/\/doi.org\/10.1016\/j.diii.2019.08.006","relation":{},"ISSN":["2211-5684"],"issn-type":[{"value":"2211-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differentiation between Fabry disease and hypertrophic cardiomyopathy with cardiac T1 mapping","name":"articletitle","label":"Article Title"},{"value":"Diagnostic and Interventional Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diii.2019.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 fran\u00e7aise de radiologie. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}